Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced on May 4, 2026, the creation of LataMed AI VE, C.A., a new Venezuelan operating subsidiary aimed at bolstering the company’s telehealth regulatory, commercialization, and healthcare deployment efforts within Venezuela.
The subsidiary is expected to serve as a localized operating entity to facilitate the phased rollout of Catalyst Crew’s telehealth platform and broader healthcare delivery infrastructure. Management anticipates that operational activities through LataMed AI VE, C.A. could begin in the coming weeks, contingent upon regulatory progress, operational readiness, and commercialization planning.
LataMed AI VE, C.A. will work alongside the company’s existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy designed to strengthen local regulatory flexibility, healthcare service operations, permit management, and long-term scalability. This move is intended to enhance the company’s ability to efficiently manage localized healthcare operations and support phased commercialization initiatives across Venezuela and other targeted Latin American markets.
The subsidiary will support patient onboarding systems, provider coordination, telehealth infrastructure deployment, regulatory compliance, commercialization planning, healthcare analytics integration, and broader operational management within the company’s evolving Latin American healthcare ecosystem. Catalyst Crew continues to advance its telehealth platform development and testing through its interface at https://latamedai.org.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.”
The company is coordinating regulatory initiatives with Venezuelan healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives. For more information, visit https://catalystcrewai.com or review the company’s SEC filings at www.sec.gov.
This development is significant for the telehealth industry and emerging markets, as it demonstrates Catalyst Crew’s commitment to building a localized infrastructure that could improve healthcare access and efficiency in underserved regions. The establishment of LataMed AI VE, C.A. positions the company to navigate regulatory complexities and scale its operations, potentially impacting healthcare delivery in Venezuela and beyond.
